Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18043738 | 1.00 | ALDH1A1 (0.41) | ALDH1A1TSHR | |
| SCHEMBL8507193 | 0.84 | ALDH1A1 (0.42) | ALDH1A1TSHR | |
| SCHEMBL5870408 | 0.84 | ALDH1A1 (0.42) | ALDH1A1TSHR | |
| SCHEMBL299523 | 0.84 | ALDH1A1 (0.42) | ALDH1A1TSHR | |
| SCHEMBL14306712 | 0.84 | ALDH1A1 (0.42) | ALDH1A1TSHR | |
| SCHEMBL9001083 | 0.79 | ALDH1A1 (0.43) | ALDH1A1TSHR | |
| SCHEMBL16585682 | 0.77 | ALDH1A1 (0.38) | ALDH1A1TSHR | |
| SCHEMBL19746245 | 0.77 | ALDH1A1 (0.38) | ALDH1A1TSHR | |
| SCHEMBL19902260 | 0.76 | ALDH1A1 (0.39) | ALDH1A1TSHR | |
| SCHEMBL16543528 | 0.75 | ALDH1A1 (0.40) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3475267-B1 | PRODUCTION OF SULFONYL AZIDE ANHYDRIDE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-04-20 | — | — | EP | claimed |
| US-10961210-B2 | Production of sulfonyl azide anhydride | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-03-30 | — | — | US | claimed |
| US-20200308127-A1 | Production of Sulfonyl Azide Anhydride | DOW GLOBAL TECHNOLOGIES LLC | 2020-10-01 | — | — | US | claimed |
| EP-3475267-B1 | PRODUCTION OF SULFONYL AZIDE ANHYDRIDE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-04-20 | — | — | EP | disclosed |
| US-10961210-B2 | Production of sulfonyl azide anhydride | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-03-30 | — | — | US | disclosed |
| US-20200308127-A1 | Production of Sulfonyl Azide Anhydride | DOW GLOBAL TECHNOLOGIES LLC | 2020-10-01 | — | — | US | disclosed |
| EP-3475267-A1 | PRODUCTION OF SULFONYL AZIDE ANHYDRIDE | Dow Global Technologies, LLC (US) | 2019-05-01 | — | — | EP | disclosed |
| WO-2017223164-A1 | PRODUCTION OF SULFONYL AZIDE ANHYDRIDE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-12-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200308127-A1 | Production of Sulfonyl Azide Anhydride | STS, CA9, CA6 | ALDH1A1 457/4885TSHR 538/4885 |
| US-10961210-B2 | Production of sulfonyl azide anhydride | STS, CA9, CA6 | ALDH1A1 438/4885TSHR 495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.